These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
54 related items for PubMed ID: 2755063
1. [Thrombocytic hemostasis and the prostaglandin system at early stages of arterial hypertension]. Kolomiets VI, Babak OIa, Starchenko TG, Volos BE. Klin Med (Mosk); 1989 Apr; 67(4):82-5. PubMed ID: 2755063 [Abstract] [Full Text] [Related]
2. [Plasma and cellular factors of atherogenesis and the prostanoid system at the early stages of arterial hypertension]. Kolomiets VI, Vasi'lev IuM. Kardiologiia; 1989 Sep; 29(9):21-5. PubMed ID: 2512410 [Abstract] [Full Text] [Related]
3. [Correlations between catecholamines and prostaglandins in patients with primary arterial hypertension and pheochromocytoma in basic conditions and after administration of clonidine]. Chojnowski K, Feltynowski T, Lazecki D, Bar-Andziak E, Ignatowska-Switalska H, Wocial B. Kardiol Pol; 1990 Sep; 33(6):396-400. PubMed ID: 2084302 [Abstract] [Full Text] [Related]
4. [The effect of prostenon on the pressor and depressor humoral systems in patients with resistant arterial hypertension]. Zeĭnalov FM, Vasil'ev IuM, Volos BE. Ter Arkh; 1990 Sep; 62(8):67-70. PubMed ID: 2274874 [Abstract] [Full Text] [Related]
5. Pathogenesis of cardiovascular disorders in streptozotocin-induced diabetes in rat. II. Correlation between lipid peroxides, thromboxane A2/prostacyclin, and platelet aggregation in different stages of diabetes. Somova L, Kamenov V, Doncheva M, Kirilov G, Vassileva M. Acta Physiol Pharmacol Bulg; 1988 Sep; 14(3):57-62. PubMed ID: 3066112 [Abstract] [Full Text] [Related]
7. [Prostaglandins in Itsenko-Cushing syndrome]. Slavnov VN, Iakovlev AA, Komissarenko IV. Klin Med (Mosk); 1989 Jun; 67(6):94-8. PubMed ID: 2779163 [Abstract] [Full Text] [Related]
8. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products]. Mevkh AT, Basevich VV, Varfolomeev SD. Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604 [Abstract] [Full Text] [Related]
9. A study of platelet aggregation, thromboxane A2 and prostacyclin in central aortic and coronary sinus blood in ischemic heart disease. Narain VS, Bhargava B, Chandra N, Puri VK, Hasan M. Indian Heart J; 1994 Dec; 46(4):149-52. PubMed ID: 7875701 [Abstract] [Full Text] [Related]
10. [Thrombocytic hemostasis and the system of vasoactive prostanoids in IHD patients with hypoalphacholesterolemia]. Chernyshov VA, Tseluĭko VI, Ladnyĭ AI, Ermakovich II. Ter Arkh; 1995 Dec; 67(6):64-6. PubMed ID: 7667787 [Abstract] [Full Text] [Related]
11. Renal prostaglandins in borderline and sustained essential hypertension. Lebel M, Grose JH. Prostaglandins Leukot Med; 1982 May; 8(5):409-18. PubMed ID: 7048332 [Abstract] [Full Text] [Related]
12. [Age-related characteristics of the prostaglandin system in healthy subjects and in patients with arterial hypertension: hypertonic disease and systolic (atherosclerotic) hypertension]. Tokar' AV, Ena LM, Negaré AI. Vestn Akad Med Nauk SSSR; 1990 May; (3):49-52. PubMed ID: 2353536 [Abstract] [Full Text] [Related]
13. [Blood levels of 6-keto-prostaglandin F1alpha, thromboxane and prostaglandin F2alpha in patients with bronchial asthma]. Grigorian LG, Chervinskaia TA. Klin Med (Mosk); 1993 May; 71(5):24-7. PubMed ID: 8301978 [Abstract] [Full Text] [Related]
14. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders. Gresele P, Blockmans D, Deckmyn H, Vermylen J. J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542 [Abstract] [Full Text] [Related]
15. [Changes in platelet function in patients with arterial hypertension]. Malý J, Pecka M, Pintérová E, Pidrman V, Bláha M, Siroký O, Jebavý L. Vnitr Lek; 1995 Jul; 41(7):458-61. PubMed ID: 7571480 [Abstract] [Full Text] [Related]
16. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin. Mueller HS, Rao PS, Greenberg MA, Buttrick PM, Sussman II, Levite HA, Grose RM, Perez-Davila V, Strain JE, Spaet TH. Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012 [Abstract] [Full Text] [Related]
17. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation. Smith JB, Araki H, Lefer AM. Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350 [Abstract] [Full Text] [Related]
18. [The role of prostacycline, thromboxane A2 and prostaglandins in platelet aggregation (author's transl)]. Herman AG. Rev Med Brux; 1981 Mar; 2(3):251-7. PubMed ID: 7015444 [No Abstract] [Full Text] [Related]
19. Treatment of hypertension with captopril: preservation of regional blood flow and reduced platelet aggregation. James IM, Dickenson EJ, Burgoyne W, Jeremy JY, Barradas MA, Mikhailidis DP, Dandona P. J Hum Hypertens; 1988 Jun; 2(1):21-5. PubMed ID: 3070031 [Abstract] [Full Text] [Related]
20. The inducible nitric-oxide synthase modulates endothelin-1-dependent release of prostacyclin and inhibition of platelet aggregation ex vivo in the mouse. Carrier E, Brochu I, de Brum-Fernandes AJ, D'Orléans-Juste P. J Pharmacol Exp Ther; 2007 Dec; 323(3):972-8. PubMed ID: 17885093 [Abstract] [Full Text] [Related] Page: [Next] [New Search]